<DOC>
	<DOC>NCT01736969</DOC>
	<brief_summary>The purpose of this study is to determine whether a developmental formulation is substantially equivalent to the predicate device in the treatment of hypertrophic and keloid scars.</brief_summary>
	<brief_title>A Substantial Equivalence Study of RD04723 and Predicate Device</brief_title>
	<detailed_description />
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Keloid</mesh_term>
	<mesh_term>Cicatrix, Hypertrophic</mesh_term>
	<criteria>Ability to provide informed consent and release health information Ability to follow study instructions and study requirements Have a hypertrophic or keloid scar accessible for treatment and evaluation Negative pregnancy test for women of childbearing potential Agreement to use effective birth control method for study duration History of allergy or sensitivity to components History of diabetes History of collagen vascular disorders Anticipated need for surgery or hospitalization during the study Pregnant, nursing, or planning a pregnancy during the study Current enrollment in an investigational drug or device study or participation in such a study within the last 30 days prior to Baseline (Day 0)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>